Latest Antifungals Stories
- Publicity Statement Claiming that Ingredient Can Affect Human Health Not Borne Out By What the Research Actually Shows WASHINGTON, Nov.
Triclosan, a common antimicrobial in personal hygiene products, causes liver fibrosis and cancer in mice
Company plans to commence clinical development of SUBA®-Itraconazole for treatment of basal cell carcinoma in patients with basal cell carcinoma nevus syndrome TAMPA, Fla.
NORTHBROOK, Ill., Nov. 3, 2014 /PRNewswire/ -- Astellas announced today that the U.S.
Zion Health announces New Anti-Itch cream formulated to relieve itching from skin rash, bug bites, and irritated skin-Now available at Berkeley Bowl Health Food store in CA. San
VANCOUVER, Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today announced next steps for its Oral Amphotericin B program.
NORTHBROOK, Ill., Oct.
MarketReportsOnline.com adds "Global Antifungal Therapeutics Market:Trends and Opportunities (2014-2019)" report to its research store. Dallas, Texas
According to a new report from BCC Research, the global market for human antifungal therapeutics is expected to grow to nearly $13.9 billion by 2018, with a five-year compound annual growth rate
- The governor of a province or people.